# AbbVie invests $195 million to expand API manufacturing in North Chicago

AbbVie announced a $195 million investment to build a new active pharmaceutical ingredient (API) manufacturing facility at its North Chicago, Illinois plant. Construction will begin in fall 2025, with full operations expected in 2027.

- Type: Expansion
- Announced: 2025-08-12
- Where: North Chicago, Illinois, United States
- Value: $195.0M
- Starts operating: 2027
- Status: announced
- Products: active pharmaceutical ingredients (APIs)
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [AbbVie](https://endata.com/companies/29401.md)

## Sources

- [news.abbvie.com](https://news.abbvie.com/2025-08-12-AbbVie-Announces-195-Million-Investment-to-Expand-Active-Pharmaceutical-Ingredient-Manufacturing-in-the-U-S), 2025-08-12: "AbbVie today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ingredient (API) production in the U.S."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.